Discover 1,005 paid clinical trials in Minneapolis, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Minneapolis currently offers various active clinical trials with a focus on many chronic conditions, including asthma, arthritis, kidney disease, and hidradenitis suppurativa. The city’s leading healthcare institutions are recruiting participants to take part in paid research studies as healthy volunteers, as well as those looking for studies targeting specific health issues, providing access to innovative treatments and contributing to the development of new therapies.
Filter
2
Filter results
Results: 1,005
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Location: Maple Grove MN, Sioux Falls SD, Fargo ND, Iowa City IA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221357
Phase 2, Phase 3, Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
for
Breast Neoplasms
Location: Maple Grove MN, Kansas City MO, Decatur IL, Detroit MI,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06926868
Phase 2, Phase 3, Recruiting
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
for
Colon Cancer, Rectal Cancer, Colorectal Cancer,
Location: Maple Grove MN, Arlington Heights IL, Columbia MO,
Sponsor: SCRI Development Innovations, LLC
Sex: All
Age: 18+
Code: NCT07011576
Phase 2, Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
Location: Coon Rapids MN, Iowa City IA, Omaha NE, Maywood IL,
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 50+
Code: NCT06455085
Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Burnsville MN, Waukee IA, Madison WI, Iowa City IA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06890884
Phase 2, Recruiting
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Burnsville MN, Marshfield WI, Niles IL, Grand Island NE,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06095505
Phase 2, Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
for
Advanced Non-Small Cell Lung Cancer,
Location: Burnsville MN, Sioux Falls SD, Omaha NE, Niles IL,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT04613596
Phase 2, Phase 3, Recruiting
A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
for
Acute Treatment of Migraine
Location: Burnsville MN, Ann Arbor MI, Dallas TX, Ridgeland MS,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07609914
Phase 4, Recruiting
Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder
for
Opioid Withdrawal, Opioid Use Disorder
Location: Center City MN
Sponsor: Spark Biomedical, Inc.
Sex: All
Age: 18 - 50
Code: NCT06487533
Recruiting
Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Saint Cloud MN, Cudahy WI, Papillion NE, Winfield IL,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06883305
Phase 3, Recruiting
Featured
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
for
Non-Small Cell Lung Cancer,
Location: Minneapolis MN, Omaha NE, Chicago IL, Grand Rapids MI,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT05005403
Phase 1, Recruiting
Featured
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Minneapolis MN, Peoria IL, Indianapolis IN,
Sponsor: AbbVie
Sex: All
Age: 2 - 17
Code: NCT06332534
Phase 3, Recruiting
Active & Responsive
Microelectrode Recordings From the Vagus Nerve in Awake Humans
for
Epilepsy
Location: Minneapolis MN
Sponsor: University of Minnesota
Sex: All
Age: 18 - 40
Code: NCT06016686
Phase 1, Recruiting
Active & Responsive
Development of a Novel Evaluation Scale of Mental Body Representation (MBR) for Adults With Spinal Cord Injury